---
title: "Xishan Science&Technology has spent 150 million yuan to repurchase 4.74% of its shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223782577.md"
description: "According to the announcement from Xishan Science&Technology, as of December 31, 2024, the company has repurchased a total of 2.3527 million shares through centralized bidding, accounting for 4.74% of the current total share capital. The highest transaction price for the repurchase was RMB 77.22 per share, and the lowest price was RMB 51.90 per share, with a total payment amounting to RMB 150 million (excluding stamp duty, transaction commissions, and other transaction costs)"
datetime: "2025-01-02T09:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223782577.md)
  - [en](https://longbridge.com/en/news/223782577.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223782577.md)
generator: "portal-rs"
---

# Xishan Science&Technology has spent 150 million yuan to repurchase 4.74% of its shares

According to the announcement from Xishan Science&Technology (688576.SH), as of December 31, 2024, the company has repurchased a total of 2.3527 million shares through centralized bidding, accounting for 4.74% of the current total share capital of the company. The highest transaction price for the repurchase was RMB 77.22 per share, the lowest price was RMB 51.90 per share, and the total amount of funds paid was RMB 150 million (excluding stamp duty, transaction commissions, and other transaction costs)

### Related Stocks

- [688576.CN](https://longbridge.com/en/quote/688576.CN.md)

## Related News & Research

- [InnoCare wins China IND clearance to trial PSMA/STEAP1 bispecific ADC ICP-B381](https://longbridge.com/en/news/298389771.md)
- [TAL: Production exceeds targets and new royalty terms improve future economics](https://longbridge.com/en/news/298178519.md)
- [Nubia sets Sept. 16 launch for Doubao-powered NaviX Ultra](https://longbridge.com/en/news/298170174.md)
- [10:58 ETClinical Science Update | New Clinical Evidence for ClotChek™](https://longbridge.com/en/news/298339206.md)
- [DoubleZero adds Kalshi’s election markets ahead of November midterms](https://longbridge.com/en/news/298492341.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**